The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells

Arindam Datta1, Jessica Jackson2, Yaroslav I Morozov1

  • 1Department of Cancer Biology, Penn Center for Genome Integrity, Basser Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Insights

Ataxia Telangiectasia Mutated (ATM) kinase deficiency causes cancer and drug sensitivity. Our study shows BRCA1-A complex loss restores drug resistance in ATM-deficient cells by enabling DNA repair pathways.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Ataxia Telangiectasia Mutated (ATM) kinase deficiency is linked to cancer susceptibility and heightened sensitivity to certain chemotherapies.
  • The BRCA1-interacting A (BRCA1-A) complex and the XRCC4/Ligase 4 complex play roles in DNA repair pathways, influencing drug resistance in ATM-deficient cells.

Purpose of the Study:

  • To investigate the role of ATM inhibition and the BRCA1-A complex in DNA damage response and drug sensitivity.
  • To elucidate the mechanisms by which BRCA1-A influences the recognition of damaged replication forks and subsequent DNA repair.

Main Methods:

  • Utilized ATM inhibition models in cancer cells.
  • Investigated SUMO and ubiquitin-mediated signaling at damaged replication forks.
  • Assessed chromatin accessibility, nuclease activity, and DNA end-resection.
  • Employed electron microscopy to visualize replication fork dynamics.

Main Results:

  • ATM inhibition triggers SUMO/ubiquitin-mediated BRCA1-A recognition of damaged forks, restricting end-resection and increasing Topoisomerase I inhibitor sensitivity.
  • BRCA1-A deficient cells exhibit increased chromatin accessibility and nuclease activity, leading to restored resection and drug resistance.
  • ATM inhibition blocks replication fork reversal, a process restored by BRCA1-A loss, generating substrates for end resection.

Conclusions:

  • BRCA1-A enforces a restrictive chromatin state that prevents the formation of DNA end-resection substrates.
  • Replication fork reversal is a critical determinant of chemotherapy response in ATM-deficient cells.
  • Targeting the BRCA1-A pathway could offer new therapeutic strategies for ATM-deficient cancers.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.5K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.3K
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
43.0K
The DNA Replication Fork01:02

The DNA Replication Fork

20.2K